| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Widdaranal A |
|
1654736-67-0 |
詳細(xì)
|
| Oseltamivir Impurity 167 |
奧司他韋雜質(zhì)167 |
16338-97-9 |
詳細(xì)
|
| Dihydro Dutasteride |
二氫度他雄胺 |
164656-22-8 |
詳細(xì)
|
| Laninamivir Impurity 2 |
拉那米韋雜質(zhì)2 |
161838-87-5 |
詳細(xì)
|
| Dabigatran Etexilate Impurity O |
達(dá)比加群酯雜質(zhì)O |
1642853-67-5 |
詳細(xì)
|
| Fluorescent Brightener 220 |
熒光增白劑220 |
16470-24-9 |
詳細(xì)
|
| 2-((tert-butyldimethylsilyl)oxy)ethyl trifluoromethanesulfonate |
2-（叔丁基二甲基硅基）氧基）乙基三氟甲烷磺酸鹽 |
164162-36-1 |
詳細(xì)
|
| Ibandronate Impurity 29 |
伊班膦酸雜質(zhì)29 |
165043-20-9 |
詳細(xì)
|
| Ethylidenenorbornene |
亞乙基降冰片烯 |
16219-75-3 |
詳細(xì)
|
| Chlorogenic acid Impurity 4 |
綠原酸雜質(zhì)4 |
1629852-63-6 |
詳細(xì)
|
| Abrocitinib |
阿布昔替尼 |
1622902-68-4 |
詳細(xì)
|
| Butylphthalide Impurity 40 |
丁苯酞雜質(zhì)40 |
162050-43-3 |
詳細(xì)
|
| Empagliflozin Impurity 117 |
恩格列凈雜質(zhì)117 |
1620758-30-6 |
詳細(xì)
|
| Regadenoson Impurity 5 |
瑞加德松雜質(zhì)5 |
1627202-38-3 |
詳細(xì)
|
| afoxolaner Impurity 20 |
阿福拉納雜質(zhì)20 |
16650-55-8 |
詳細(xì)
|
| Adipic Acid Bis-2-Ethylhexyl Ester |
依澤替米貝雜質(zhì)140 |
163222-31-9 |
詳細(xì)
|
| ethyl dihydrogen phosphate |
磷酸單乙基酯 |
1623-14-9 |
詳細(xì)
|
| Atropine Impurity 30 |
阿托品雜質(zhì)30 |
16655-60-0 |
詳細(xì)
|
| Rosuvastatin Impurity 168 |
瑞舒伐他汀雜質(zhì)168 |
1659301-71-9 |
詳細(xì)
|
| 4-Nitrosomethylaminopyridine |
4-亞硝基甲基氨基吡啶 |
16219-99-1 |
詳細(xì)
|
| (6-methoxypyridin-3-yl)boronic acid |
（6-甲氧基吡啶-3-基）硼酸 |
163105-89-3 |
詳細(xì)
|
| Empagliflozin Impurity 96 |
恩格列凈雜質(zhì)96 |
1620758-21-5 |
詳細(xì)
|
| Venetoclax Impurity 2 |
維奈妥拉雜質(zhì)2 |
1628047-90-4 |
詳細(xì)
|
| Avanafil Impurity 47 |
阿伐那非雜質(zhì)47 |
1638497-25-2 |
詳細(xì)
|
| Letermovir Impurity 38 |
萊特莫韋雜質(zhì)38 |
16588-75-3 |
詳細(xì)
|
| Cabozantinib Impurity 61 |
卡博替尼雜質(zhì)61 |
1628530-41-5 |
詳細(xì)
|
| Bilastine impurity 43 |
比拉斯汀雜質(zhì)43 |
1638785-15-5 |
詳細(xì)
|
| Axitinib Impurity 36 |
阿西替尼雜質(zhì)36 |
1639138-00-3 |
詳細(xì)
|
| Chlortetracycline EP Impurity J;Lymecycline EP Impurity C;Anhydrotetracycline |
金霉素EP雜質(zhì)J；萊姆霉素EP雜質(zhì)C；脫水四環(huán)素 |
1665-56-1 |
詳細(xì)
|
| Cycloserine Diketoperazine |
環(huán)絲氨酸二酮哌嗪 |
16337-02-3 |
詳細(xì)
|
| Suvorexant Impurity 5 |
蘇沃雷生雜質(zhì)5 |
1638743-92-6 |
詳細(xì)
|
| Esaxerenone |
艾沙利酮 |
1632006-28-0 |
詳細(xì)
|
| 2,3,6-trihydroxybenzoic acid |
2,3,6-三羥基苯甲酸 |
16534-78-4 |
詳細(xì)
|
| Cyclandelate Impurity 1 |
環(huán)扁桃酯雜質(zhì)1 |
16623-22-6 |
詳細(xì)
|
| Perampanel Impurity 23 |
吡侖帕奈雜質(zhì)23 |
1628-89-3 |
詳細(xì)
|
| Posaconazole Impurity 240 |
泊沙康唑雜質(zhì)240 |
165115-74-2 |
詳細(xì)
|
| Gadobutrol Impurity 101 |
釓布醇雜質(zhì)101 |
162148-48-3 |
詳細(xì)
|
| 4-ethoxypyridin-3-amine |
4-乙氧基吡啶-3-胺 |
1633-43-8 |
詳細(xì)
|
| Ponatinib RC 6 |
普納替尼 RC 6 |
1638193-95-9 |
詳細(xì)
|
| (+)-phytocassane B |
|
166547-22-4 |
詳細(xì)
|
| Tryptophan EP Impurity J; N-Acetyltryptophan EP Impurity J |
色氨酸EP雜質(zhì)J；N-乙酰色氨酸EP雜質(zhì)J |
164068-19-3 |
詳細(xì)
|
| Cinacalcet Impurity 140 |
西那卡塞雜質(zhì)140 |
1630761-22-6 |
詳細(xì)
|
| Tegoprazan Impurity 7 |
特戈拉贊雜質(zhì)7 |
1640981-20-9 |
詳細(xì)
|
| dimethyl 2,2-dipropylmalonate |
2,2-二丙基丙二酸二甲酯 |
16644-05-6 |
詳細(xì)
|
| 1-methylcyclopropane-1-carbonyl chloride |
1-甲基環(huán)丙烷-1-羰基氯 |
16480-05-0 |
詳細(xì)
|
| Nintedanib Impurity 56 |
尼達(dá)尼布雜質(zhì)56 |
1624587-84-3 |
詳細(xì)
|
| Cloxacillin Sodium EP Impurity A |
氯唑西林鈉EP雜質(zhì)A |
1642629-96-6 |
詳細(xì)
|
| Cabozantinib Impurity 60 |
卡博替尼雜質(zhì)60 |
1628530-38-0 |
詳細(xì)
|
| Azithromycin-D3 |
偶氮霉素-D3 |
163921-65-1 |
詳細(xì)
|
| 13-cis-crocin 3 |
13順式西紅花苷3 |
164454-41-5 |
詳細(xì)
|
| Fluralaner Impurity 17 |
氟雷拉納雜質(zhì)17 |
1655515-91-5 |
詳細(xì)
|
| Mirogabalin Impurity 23 |
米洛巴林雜質(zhì)23 |
1644251-71-7 |
詳細(xì)
|
| Ulipristal Acetate Impurity H |
醋酸烏利司他雜質(zhì)H |
1655514-84-3 |
詳細(xì)
|
| Avanafil Impurity 74 |
阿伐那非雜質(zhì)74 |
1643811-21-5 |
詳細(xì)
|
| Fenhexamid |
比拉斯汀雜質(zhì)36 |
1638785-22-4 |
詳細(xì)
|
| Azvudine Impurity 11 |
阿茲夫定雜質(zhì)11 |
1631061-80-7 |
詳細(xì)
|
| Fluoxetine Impurity 37 |
氟西汀雜質(zhì)37 |
1624625-05-3 |
詳細(xì)
|
| Minodronic Acid Impurity 27 |
米諾膦酸雜質(zhì)27 |
164733-64-6 |
詳細(xì)
|
| 8-hydroxy-3-methyl-1-oxoisochromane-7-carboxylic acid |
8-羥基-3-甲基-1-氧異鉻-7-羧酸 |
16281-43-9 |
詳細(xì)
|
| Amitraz Impurity 2 |
雙甲脒雜質(zhì)2 |
16596-04-6 |
詳細(xì)
|
| Sitagliptin-D4 |
西他列汀-d4 |
1620233-72-8 |
詳細(xì)
|
| ML381(VU0488130) |
ML381(VU0488130) |
1623481-80-0 |
詳細(xì)
|
| Alendronic Acid Impurity 2 |
阿侖膦酸雜質(zhì)2 |
165043-19-6 |
詳細(xì)
|
| Tenofovir Impurity 237 |
替諾福韋雜質(zhì)237 |
1643116-23-7 |
詳細(xì)
|
| L-Valine, N-(methoxycarbonyl)-3-methyl |
N-（甲氧羰基）-3-甲基L-纈氨酸 |
162537-11-3 |
詳細(xì)
|
| (S)-N-((3-(3,4-difluorophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide |
（S） -N-（3-（3,4-二氟苯基）-2-氧代惡唑烷-5-基）甲基）乙酰胺 |
1644566-19-7 |
詳細(xì)
|
| Cis-Epoxysuccinate |
順環(huán)氧琥珀酸 |
16533-72-5 |
詳細(xì)
|
| (2R,3R,4S,5R,6R)-2-((R)-2,3-dihydroxypropoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
（2R，3R，4S，5R，6R）-2-（（R）-2,3-二羥基丙氧基）-6-（羥甲基）四氫-2H-吡喃-3,4,5-三醇 |
16232-91-0 |
詳細(xì)
|
| Azilsartan Impurity 81 |
阿齊沙坦雜質(zhì)81 |
16533-45-2 |
詳細(xì)
|
| Baricitinib Impurity 55 |
巴瑞克替尼雜質(zhì)55 |
1638759-68-8 |
詳細(xì)
|
| Axitinib Impurity N |
阿昔替尼雜質(zhì)27 |
1639137-80-6 |
詳細(xì)
|
| Docetaxel Impurity 53 |
多西他賽雜質(zhì)53 |
165173-47-7 |
詳細(xì)
|
| Moxifloxacin Impurity 183 |
莫西沙星雜質(zhì)183 |
1620445-12-6 |
詳細(xì)
|
| Febuxostat Impurity 94 |
非布索坦雜質(zhì)94 |
1643131-93-4 |
詳細(xì)
|
| Carbofuran-3-hydroxy |
3-羥基呋喃丹 |
16655-82-6 |
詳細(xì)
|
| Ritonavir Impurity 57 |
利托那韋雜質(zhì)57 |
165316-09-6 |
詳細(xì)
|
| 3-Hydroxyhippuric acid |
3-羥基馬尿酸 |
1637-75-8 |
詳細(xì)
|
| Lysine Impurity 31 |
賴氨酸雜質(zhì)31 |
1621187-55-0 |
詳細(xì)
|
| Selamectin EP Impurity A |
塞拉菌素EP雜質(zhì)A |
165108-08-7 |
詳細(xì)
|
| Alfacalcidol-D6 |
阿法骨化醇-D6 |
1641940-94-4 |
詳細(xì)
|
| 3-amino-4-hydroxybenzaldehyde |
3-氨基-4-羥基苯甲醛 |
163036-58-6 |
詳細(xì)
|
| 1-Xylosyluracil |
1-木糖基賴氨酸 |
16535-78-7 |
詳細(xì)
|
| Tebipenem Pivoxil Impurity 14 |
泰比培南酯雜質(zhì)14 |
1665289-91-7 |
詳細(xì)
|
| Pyridoxine N-Oxide |
N-氧化吡哆醇 |
16567-04-7 |
詳細(xì)
|
| Chlorosulfonic acid phenyl ester |
氯磺酸苯基酯 |
16475-29-9 |
詳細(xì)
|
| Ceritinib D7 |
色瑞替尼D7 |
1632484-77-5 |
詳細(xì)
|
| Bromhexine EP Impurity I |
溴己新EP雜質(zhì)I |
|
詳細(xì)
|
| Droxidopa Impurity 5 |
屈西多巴雜質(zhì)5 |
16322-99-9 |
詳細(xì)
|
| Posaconazole Impurity 256 |
泊沙康唑雜質(zhì)256 |
165115-70-8 |
詳細(xì)
|
| Lacosamide Impurity 49 |
拉科酰胺雜質(zhì)49 |
1629130-53-5 |
詳細(xì)
|
| Amoxicillin EP Impurity D |
阿莫西林EP雜質(zhì)D |
1642629-94-4 |
詳細(xì)
|
| (dibromomethyl)cyclopropane |
（二溴甲基）環(huán)丙烷 |
1619237-71-6 |
詳細(xì)
|
| N-methoxy-N-methylnitrous amide |
N-甲氧基-N-甲基亞硝酸酰胺 |
16339-12-1 |
詳細(xì)
|
| Lenalidomide Impurity 54 |
來那度胺雜質(zhì)54 |
1628915-10-5 |
詳細(xì)
|
| Salvianolic acid Y |
丹酚酸Y |
1638738-76-7 |
詳細(xì)
|
| Abiraterone Impurity 58 |
阿比特龍雜質(zhì)58 |
1620323-43-4 |
詳細(xì)
|
| tert-Butyl acrylate |
丙烯酸叔丁酯 |
1663-39-4 |
詳細(xì)
|
| Linagliptin Impurity 132 |
利格列汀雜質(zhì)132 |
1620278-39-8 |
詳細(xì)
|
| N-[2-(4-Morpholinyl)acetyl]-L-alanine |
N-[2-（4-嗎啉基）乙?；鵠-L-丙氨酸 |
1629680-22-3 |
詳細(xì)
|
| ethyl 5-amino-4-oxopentanoate |
5-氨基-4-氧代戊酸乙酯 |
163271-25-8 |
詳細(xì)
|